Despite some negative reports (Takenaka et al., 2015; Teira et al., 2016) and controversial results, the cooperative effects of KIR–ligand mismatch in reducing AML relapse by CMV reactivation have been reported (Yokoyama et al., 2021b). This evidence concerns the gene KIR3DL1 and acute myeloid leukemia.